)

Biocatalysis - A cornerstone of industrial innovation 05/25

In an era where sustainable manufacturing is no longer optional but imperative, biocatalysis is emerging as a cornerstone of industrial innovation.

The recent Young Inventors Prize 2025 by the European Patent Office showcases this transformation, highlighting how enzyme-based solutions are moving from academic labs to industrial reality.

Two groundbreaking innovations particularly demonstrate this shift:

Ruby Laboratories' cell-free biocatalysis platform, turning CO₂ into essential materials for industry leaders, and
Biomatter's AI-powered enzyme design platform, revolutionising biomanufacturing efficiency.

These achievements underscore a crucial message: biocatalysis is no longer a niche technology—it's a fundamental driver of sustainable manufacturing's future.

As we explore the convergence of enzymatic processes, AI-driven innovation, and industrial-scale implementation in this newsletter, we'll show how the Enzyme Technology Alliance and SpinChem's technologies are contributing to this transformation.

Advancing Biocatalysis through the Enzyme Technology Alliance (ETA)

In today’s rapidly evolving biocatalysis landscape, seamless integration across discovery, development, and manufacture is more critical than ever. Recognising this need for end-to-end collaboration, the Enzyme Technology Alliance was established to address a fundamental challenge: no single provider can span the entire journey from enzyme discovery to commercial process.

Enzyme Technology Alliance Sequence to Value

By uniting seven European biotech SMEs - Aminoverse, ChiralVision, Enzymicals, Allozymes, SpinChem, Bio-Prodict, and Candidum - ETA delivers a cohesive “Sequence to Value” offering. Under this framework, partners combine complementary expertise in in silico discovery, AI-driven enzyme engineering, ultra-high-throughput screening, tailored immobilisation, reactor design, and full-scale manufacturing .

What This Means for You

Design & Discovery: Advanced bioinformatics and AI-supported engineering rapidly yield optimised enzyme candidates.
Production & Immobilisation: Scalable expression platforms and bespoke carrier strategies produce robust, reusable biocatalysts.
Seamless Scale-Up: SpinChem’s Rotating Bed Reactor seamlessly integrates immobilised enzymes, preserving lab-scale kinetics through to multi-tonne operations.
Predictable, Sustainable Outcomes: A single-partner engagement model streamlines communication, reduces risk, and delivers clear milestones—accelerating development while minimising waste.

Curious how ETA’s “Sequence to Value” pipeline can streamline your enzyme development and manufacturing goals?

Reach out to us at SpinChem, to explore tailored solutions for your biocatalysis challenges.

Learn how Enzyme Technology Alliance can help in your process

Meet ETA & SpinChem at Biotrans 2025

In parallel with our ETA collaboration, we look forward to engaging with you at Biotrans 2025—where the Alliance takes centre stage as a Gold Sponsor, and SpinChem showcases its RBR technology in action.

When & Where: 29 June–3 July 2025, Congress Centre Basel, Switzerland

Booth #8 (adjacent to the poster area)

Connect with ETA Partners: Discover integrated solutions in enzyme discovery, immobilisation, and scale-up alongside Aminoverse, ChiralVision, Enzymicals, Allozymes, Bio-Prodict, Candidum—and SpinChem’s RBR technology.

Live Demonstrations:

Full-scale RBR: See our continuous-flow Rotating Bed Reactor in operation.

MiniRBR Preview:

We are pleased to announce the upcoming launch of our long-awaited SpinChem MiniRBR system at Biotrans 2025. This compact reactor provides rapid screening of heterogeneous biocatalytic reactions in millilitre volumes, significantly enhancing laboratory-scale process development.

Ideal for:

R&D departments
Process development teams
Scale-up studies
Method optimization
Academic research laboratories

Complimentary Micro-Consultations: Book a 15-minute session with a SpinChem engineer to discuss your process challenges, enzyme immobilization strategies, and RBR integration. Use our online calendar to reserve your slot.

As we move forward in 2025, the synergy between ETA's comprehensive expertise and SpinChem's innovative reactor technology positions us uniquely to address the evolving needs of industrial biocatalysis.

We invite you to join us on this journey toward more efficient, sustainable, and scalable bioprocesses. For the latest updates on our technologies and collaborations, follow us on LinkedIn or visit our website.